These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23648139)

  • 1. Nuclear β-catenin accumulation is associated with increased expression of Nanog protein and predicts poor prognosis of non-small cell lung cancer.
    Li XQ; Yang XL; Zhang G; Wu SP; Deng XB; Xiao SJ; Liu QZ; Yao KT; Xiao GH
    J Transl Med; 2013 May; 11():114. PubMed ID: 23648139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
    Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of differential β-catenin expression with Oct-4 and Nanog in oral squamous cell carcinoma and their correlation with clinicopathological factors and prognosis.
    Ravindran G; Sawant SS; Hague A; Kingsley K; Devaraj H
    Head Neck; 2015 Jul; 37(7):982-93. PubMed ID: 24700702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of nuclear localization of SHP2 and YAP1 with unfavorable prognosis in non-small cell lung cancer.
    Chen MJ; Wang YC; Wu DW; Chen CY; Lee H
    Pathol Res Pract; 2019 Apr; 215(4):801-806. PubMed ID: 30685130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis.
    Zhang S; Wang Y; Dai SD; Wang EH
    BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EPB41 suppresses the Wnt/β-catenin signaling in non-small cell lung cancer by sponging ALDOC.
    Yuan J; Xing H; Li Y; Song Y; Zhang N; Xie M; Liu J; Xu Y; Shen Y; Wang B; Zhang L; Yang M
    Cancer Lett; 2021 Feb; 499():255-264. PubMed ID: 33242559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
    Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
    Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBP1 promoter methylation augments the oncogenic β-catenin to correlate with prognosis in NSCLC.
    Tseng RC; Huang WR; Lin SF; Wu PC; Hsu HS; Wang YC
    J Cell Mol Med; 2014 Sep; 18(9):1752-61. PubMed ID: 24895061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Bmi1, FoxF1, Nanog, and γ-catenin in relation to hedgehog signaling pathway in human non-small-cell lung cancer.
    Gialmanidis IP; Bravou V; Petrou I; Kourea H; Mathioudakis A; Lilis I; Papadaki H
    Lung; 2013 Oct; 191(5):511-21. PubMed ID: 23864317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant Wnt1/β-catenin expression is an independent poor prognostic marker of non-small cell lung cancer after surgery.
    Xu X; Sun PL; Li JZ; Jheon S; Lee CT; Chung JH
    J Thorac Oncol; 2011 Apr; 6(4):716-24. PubMed ID: 21336184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective.
    Gao X; Cai Y; Wang Z; He W; Cao S; Xu R; Chen H
    J Transl Med; 2019 Sep; 17(1):308. PubMed ID: 31511014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of BarH-like homeobox 2 promotes cell proliferation, migration and aerobic glycolysis through Wnt/β-catenin signaling, and predicts a poor prognosis in non-small cell lung carcinoma.
    Chen H; Zhang M; Zhang W; Li Y; Zhu J; Zhang X; Zhao L; Zhu S; Chen B
    Thorac Cancer; 2018 Mar; 9(3):390-399. PubMed ID: 29341468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EGF-induced nuclear localization of SHCBP1 activates β-catenin signaling and promotes cancer progression.
    Liu L; Yang Y; Liu S; Tao T; Cai J; Wu J; Guan H; Zhu X; He Z; Li J; Song E; Zeng M; Li M
    Oncogene; 2019 Jan; 38(5):747-764. PubMed ID: 30177836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer.
    Dai SD; Wang Y; Miao Y; Zhao Y; Zhang Y; Jiang GY; Zhang PX; Yang ZQ; Wang EH
    BMC Cancer; 2009 Jun; 9():178. PubMed ID: 19508730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of high-grade pulmonary neuroendocrine carcinomas shows up-regulation of matrix metalloproteinase-7 associated with nuclear beta-catenin immunoreactivity, independent of EGFR and HER-2 gene amplification or expression.
    Pelosi G; Scarpa A; Veronesi G; Spaggiari L; Del Curto B; Moore PS; Maisonneuve P; Sonzogni A; Masullo M; Viale G
    Virchows Arch; 2005 Dec; 447(6):969-77. PubMed ID: 16158183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression and cytoplasmic accumulation of Hepl is associated with clinicopathological parameters and poor prognosis in non-small cell lung cancer.
    Miao Y; Wang L; Liu Y; Li AL; Liu SL; Cao HY; Zhang XP; Jiang GY; Liu D; Wang EH
    Tumour Biol; 2013 Feb; 34(1):107-14. PubMed ID: 23001926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated expression of DKK1 is associated with cytoplasmic/nuclear beta-catenin accumulation and poor prognosis in hepatocellular carcinomas.
    Yu B; Yang X; Xu Y; Yao G; Shu H; Lin B; Hood L; Wang H; Yang S; Gu J; Fan J; Qin W
    J Hepatol; 2009 May; 50(5):948-57. PubMed ID: 19303159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
    Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
    PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic silencing of AXIN2/betaTrCP and deregulation of p53-mediated control lead to wild-type beta-catenin nuclear accumulation in lung tumorigenesis.
    Tseng RC; Lin RK; Wen CK; Tseng C; Hsu HS; Hsu WH; Wang YC
    Oncogene; 2008 Jul; 27(32):4488-96. PubMed ID: 18372914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.